Matthew Fordham
Cardiovascular Disease · Albany, NYNPI 1659909349
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Abiomed at 33.6% of the total.
Across 73 payments — averaging $42.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$1K
- Boston Scientific$593
- Abbott$248
- AstraZeneca$214
- Edwards Lifesciences$210
- Cvrx, Inc.$135
- plus $652 from 16 others
What the payments were for
- Food & beverage$2,95896%
- Education$1334%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 15 | $1,039 |
| Boston Scientific | 6 | $593 |
| Abbott | 6 | $248 |
| AstraZeneca | 5 | $214 |
| Edwards Lifesciences | 9 | $210 |
| Cvrx, Inc. | 6 | $135 |
| Shockwave Medical, Inc | 1 | $113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $110 |
| Scpharmaceuticals Inc. | 5 | $92 |
| Bridgebio Pharma, Inc. | 3 | $54 |
| Kestra Medical Technology Services, Inc. | 2 | $43 |
| Bayer | 2 | $38 |
| Novo Nordisk | 2 | $35 |
| Baxter Healthcare | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Novartis | 1 | $20 |
| Chiesi USA, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,092 in reported general payments places this provider in the 60th percentile of 2,302 cardiovascular disease providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Albany
- Augustin DelagoAlbany$1.8M
- Rizwan AlimohammadAlbany$349K
- Edward PhilbinAlbany$226K
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.